Poland· PL-100370716
Lonsurf
A trifluridin, kombinationen product containing trifluridinum + tipiracilum, registered in Poland by Les Laboratoires Servier. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Trifluridin, kombinationen is registered in 11 of 19 countries.
Countries holding a registration under ATC L01BC59 (trifluridin, kombinationen), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Trifluridin, kombinationen · ATC L01BC59
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of trifluridin, kombinationen costs, country by country.
Normalised to the WHO defined daily dose (45 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Trifluridin, kombinationen · price per daily dose (45 mg)
USD · FX 28 Sept 2026
- CH Switzerland$126.56
The record
At a glance
URPL (Poland)- Active substance
- Trifluridinum + Tipiracilum
- Manufacturer
- Les Laboratoires Servier
- Country
- Poland (PL)
- ATC code
- L01BC59
- ATC class
- Trifluridin, Kombinationen
- Defined daily dose
- 45 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05901571320632
- gtin05901571320649
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
72 interactions on record for trifluridin, kombinationen.
Graded by severity as the source publishes them — 29 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Trifluridin, kombinationen · interactions on record
72 records
- 29 severe
- 43 moderate
Most severe, free to view
- CladribineL01BB04severe
- Talimogene laherparepvecL01XL02severe
- Talimogen laherparepvecL01XX51severe
- LeflunomidL04AA13severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Trifluridin, kombinationen in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaLONSURFLes Laboratoires Servier, Suresnes cedex
- United StatesLONSURFTaiho Pharmaceutical Co., Ltd.
- SpainLONSURF 15 MG/6,14 MG COMPRIMIDOS RECUBIERTOS CON PELICULALes Laboratoires Servier
- SwitzerlandLonsurf 15 mg/6.14 mg, comprimés pelliculésServier (Suisse) SA
- NetherlandsLonsurf 15 mg, filmomhulde tablettenTaiho Pharma Europe Ltd.
- FinlandLonsurfOrifarm Oy
- FranceLONSURF 15 mg/6,14 mg, comprimé pelliculéLES LABORATOIRES SERVIER
- United KingdomLonsurf 15mg/6.14mg tabletsServier Laboratories Ltd
Authorised across Europe · EMA
The same active substance is authorised in 8 EEA countries. Names it is sold under:
- Belgium · Trifluridine/Tipiracil Eugia
- Spain · Trifluridina/Tipiracilo Eugia
- Iceland · Lonsurf
- Liechtenstein · Lonsurf
- Luxembourg · Trifluridine/Tipiracil Eugia
- Netherlands · Trifluridine, Tipiracil Eugia
- Norway · Lonsurf
- Portugal · Trifluridina + Tipiracilo Eugia
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b29497b3-5256-46c5-8ae8-7954d4024c86 GET /v1/drugs/b29497b3-5256-46c5-8ae8-7954d4024c86?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "20 mg + 8,19 mg",
"packaging": "05901571320632 ¦ Rpz ¦ EU/1/16/1096/004 ¦ 115807\n20 tabl.\nRpz ¦ EU/1/16/1096/005 ¦ 115808\n40 tabl.\n05901571320649 ¦ Rpz ¦ EU/1/16/1096/006 ¦ 115809\n60 tabl.",
"substance": "Trifluridinum 20 mg + Tipiracilum 8,19 mg",
"common_name": "Trifluridinum + Tipiracilum",
"pl_product_id": "100370716",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about trifluridin, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.